StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN)

StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN) in a report published on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock.

Separately, Alliance Global Partners restated a “buy” rating on shares of Evogene in a report on Friday, March 7th.

Evogene Price Performance

Shares of NASDAQ EVGN opened at $1.17 on Friday. Evogene has a one year low of $0.95 and a one year high of $9.00. The firm’s 50 day simple moving average is $1.26 and its two-hundred day simple moving average is $1.57. The stock has a market capitalization of $6.28 million, a P/E ratio of -0.26 and a beta of 1.37.

Evogene (NASDAQ:EVGN) last issued its quarterly earnings results on Thursday, March 6th. The biotechnology company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of ($0.72) by $0.78. Evogene had a negative net margin of 314.43% and a negative return on equity of 109.05%. The business had revenue of $1.61 million for the quarter, compared to analysts’ expectations of $3.63 million. During the same period last year, the business earned ($1.30) earnings per share.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Evogene stock. Citadel Advisors LLC acquired a new stake in shares of Evogene Ltd. (NASDAQ:EVGN) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 15,891 shares of the biotechnology company’s stock, valued at approximately $30,000. Citadel Advisors LLC owned 0.30% of Evogene at the end of the most recent quarter. Institutional investors and hedge funds own 10.40% of the company’s stock.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.